Could a gentler cancer staging method spare women from harsh side effects?
NCT ID NCT02598219
First seen Feb 01, 2026 · Last updated Apr 27, 2026 · Updated 12 times
Summary
This study tests whether a targeted 'sentinel node' biopsy works as well as the usual more extensive lymph node removal in women with early-stage endometrial cancer that has a medium or high chance of coming back. About 262 participants are randomly assigned to either the new or standard approach. The main goal is to see if the sentinel method causes fewer complications during and shortly after surgery, while still accurately detecting cancer spread.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON ENDOMETRIOID CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Georges François Leclerc
Dijon, France
-
Centre Hospitalier Régional Universitaire
Besançon, 25000, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Léon Bérard
Lyon, 69008, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre Paul Strauss
Strasbourg, 67065, France
-
Hôpital Européen Georges Pompidou
Paris, 75015, France
-
Hôpital Jeanne de Flandres, CHRU Lille
Lille, 59037, France
-
Hôpital La Pitié-Salpêtrière
Paris, 75013, France
-
Hôpital Mère-Enfant, CHU Limoges
Limoges, 87042, France
-
ICM Val d'Aurelle
Montpellier, 34298, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Regaud
Toulouse, 31059, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut de Cancérologie de l'Ouest, René Gauducheau
Saint-Herblain, 44805, France
-
Polyclinique Urbain V
Avignon, 84036, France
Conditions
Explore the condition pages connected to this study.